Michael Smith is an accomplished professional in the biopharmaceutical industry with extensive experience in drug product development and nanoparticle formulation. Currently serving as a Director at Moderna since April 2014, previous roles include Associate Director, Principal Scientist, and Senior Scientist. At Merck, Michael contributed as a Senior Scientist, focusing on siRNA lipid nanoparticles and formulation optimization. Michael's academic background includes a PhD in Chemistry from Georgia Institute of Technology, where research involved nano-sized hydrogels for cancer therapy, as well as participation in the TI:GER program. Prior internship experiences at Wyeth Research and Wyeth Pharmaceuticals provided foundational insights in clinical trial operations and quality control.
This person is not in any offices